Inozyme Pharma Inc logo

Inozyme Pharma Inc Share Price INZY

$4

▲

0.01

(0.25%)

Last updated on

Bell Icon

This instrument is not available for trading on the INDmoney app on 30 Jun 2025

Check the interactive Inozyme Pharma Inc Stock chart to analyse performance

Inozyme Pharma Inc Key Stats

Check Inozyme Pharma Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$3.99
Open
$4.0
Market Capitalization
$257.6M
Today's Volume
$1.5M
Revenue TTM
$0.0
EBITDA
$-104.7M
Earnings Per Share (EPS)
$-1.68
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-141.69%

Global Institutional Holdings in Inozyme Pharma Inc

  • Name

    Holdings %

  • Adage Capital Partners Gp LLC

    7.99%

  • Pivotal bioVenture Partners Investment Advisor LLC

    6.96%

  • Sofinnova Ventures

    6.63%

  • Affinity Asset Advisors, LLC

    5.99%

  • BlackRock Inc

    5.80%

  • Rock Springs Capital Management LP

    5.34%

Analyst Recommendation on Inozyme Pharma Inc Stock

Rating
Trend

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Inozyme Pharma Inc(by analysts ranked 0 to 5 stars)

About Inozyme Pharma Inc

Inozyme Pharma, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for rare diseases that affect bone health and blood vessel function. The company's lead product candidate consists of INZ-701, a soluble, recombinant, genetically engineered, and ENPP1 fusion protein for the treatment of ENPP1 and ABCC6 deficiencies, and calciphylaxis, as well as patients with end-stage kidney disease receiving hemodialysis. It also develops Next Gen ERT for the treatment of ossification of the posterior longitudinal ligament (OPLL); and Gene therapy, a disease of the PPi-Adenosine Pathway. The company has license agreement with Yale University for specified therapeutic and prophylactic products. Inozyme Pharma, Inc. was incorporated in 2015 and is headquartered in Boston, Massachusetts.
Organization
Inozyme Pharma Inc
Employees
67
CEO
Dr. Douglas A. Treco Ph.D.
Industry
Health Technology

Key Management of Inozyme Pharma Inc

NameTitle
Dr. Douglas A. Treco Ph.D.
CEO & Chairman
Mr. Axel Bolte M.B.A., M.Sc.
Co-Founder, Senior Advisor & Director
Mr. Sanjay S. Subramanian M.B.A., M.S.
CFO, Head of Business Development, Principal Accounting Officer & Corporate Secretary
Dr. Matthew Winton Ph.D.
Senior VP & COO
Dr. Demetrios Braddock M.D., Ph.D.
Co-Founder, Scientific Founder, Member of Scientific Advisory Board & Board Observer
Dr. Yves Sabbagh Ph.D.
Senior VP, Chief Scientific Officer & Chair of the Scientific Advisory Board
Mr. Stefan Riley
Director of Investor Relations
Ms. Gayle Gironda
Senior VP & Chief People Officer
Mr. Stephen J. Di Palma M.B.A.
Consultant
Dr. Petra Duda M.D., Ph.D.
Chief Medical Officer

Important FAQs about investing in INZY Stock from India :

What is Inozyme Pharma Inc share price today?

Inozyme Pharma Inc share price today is $4.00 as on at the close of the market. Inozyme Pharma Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Inozyme Pharma Inc share?

Inozyme Pharma Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Inozyme Pharma Inc stock price today i.e. is closed at $4.00, lower by 35.9% versus the 52 week high.

How to invest in Inozyme Pharma Inc Stock (INZY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Inozyme Pharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Inozyme Pharma Inc Shares that will get you 0.3750 shares as per Inozyme Pharma Inc share price of $4.00 per share as on June 30, 2025 at 12:00 am IST.

What is the minimum amount required to buy Inozyme Pharma Inc Stock (INZY) from India?

Indian investors can start investing in Inozyme Pharma Inc (INZY) shares with as little as ₹96.815 or $1 (as of May 21, 2026) using the INDmoney app.
For example: If you want to invest $10 or ₹968.15 in Inozyme Pharma Inc stock (as per the Rupee-Dollar exchange rate as on May 21, 2026). Based on Inozyme Pharma Inc share’s latest price of $4.00 as on June 30, 2025 at 12:00 am IST, you will get 2.5000 shares of Inozyme Pharma Inc. Learn more about fractional shares .

What are the returns that Inozyme Pharma Inc has given to Indian investors in the last 5 years?

Inozyme Pharma Inc stock has given 0.0% share price returns and 32.93% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?